As Teva wins U.S. approval for GSK Advair copy, main fight yet to come

LONDON (Reuters) – Israel’s Teva Pharmaceutical Industries has won U.S. approval to market a copy of GlaxoSmithKline’s best-selling Advair inhaler, although the real battle is still to come.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *